Sky Labs

Sky Labs is a health care startup founded in 2015, with a focus on developing a ring-type Cardio Tracker called CART for continuous monitoring of atrial fibrillation, a condition often challenging to diagnose. The company's slogan, "Experience Seamless Heart Health Monitoring with Innovative Precision," encapsulates its mission. Atrial fibrillation affects a significant portion of the population, and Sky Labs aims to address the underdiagnosis of this condition. CART aims to provide continuous monitoring with essential features, including wearable comfort, zero user intervention, and medical accuracy. It is designed to be water-proof and dust-proof, allowing users to wear it during daily activities. The device performs measurements automatically, ensuring user convenience. Furthermore, it adheres to conventional cardiologist methods for accurate diagnoses. Sky Labs targets a substantial initial market of 200,000 atrial fibrillation patients in Finland, with a broader market of 300 million individuals needing diagnosis and millions involved in clinical trials. The company has secured a KRW20.70B Series C investment on 22 September 2023, with prominent investors such as Korea Development Bank, Devsisters Ventures, K2 Investment Partners, SJG Partners, and Open Water Investment participating in the funding round. Currently, Sky Labs is validating CART's performance through clinical trials with Seoul National University Hospital and collaborating with global pharmaceutical company Bayer on innovative healthcare initiatives. This strategic approach underlines the company's commitment to leveraging partnerships and cutting-edge research to advance its groundbreaking solution in the health care industry.